Nirsevimab Resource Toolkit for Pediatric Practices
Nirsevimab, the new monoclonal antibody for prevention of RSV disease in infants and young children, has recently been approved by the FDA and recommended by the CDC and AAP. To assist in nirsevimab’s introduction into your practice, we have compiled a “toolkit” of resources covering everything from its recommended use to storage to coding and billing and more.